Rincon Bio performs U87-MG xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
U87-MG cells were derived from a 44 year old male patient with GBM. In this subcutaneous model for GBM, the cells are injected into the flank of the mouse
Forms tumors in nude mice
Used in xenografts to test the efficacy of novel cancer therapeutics
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are easy to work with. And we take a personal interest in our clients and their studies.